a year ago
LONA
AnalystsGraig SuvannavejhGraig Suvannavejh's Stock Forecasts
AnalystsGraig Suvannavejh
Analyst Ranking
Top 6%
#289 out of 5206 analysts
Average Return
+16.96%
Win Rate
55%83 out of 150
Risk vs Reward
Poor
Good
Graig Suvannavejh's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Terns Pharmaceuticals IncTERN | +417.44% | $8.14 | $42.12 | 2025-10-22 - 2026-02-27 | Buy |
Corvus Pharmaceuticals IncCRVS | +396.20% | $3.68 | $18.26 | 2025-05-20 - 2026-02-27 | Buy |
Amylyx Pharmaceuticals IncAMLX | +338.44% | $3.46 | $15.17 | 2025-04-07 - 2026-02-27 | Buy |
Erasca IncERAS | +313.94% | $3.30 | $13.66 | 2025-12-09 - 2026-02-27 | Buy |
Insmed IncINSM | +266.11% | $20.36 | $74.54 | 2023-07-26 - 2024-07-26 | Strong Buy |
Graig Suvannavejh Analyst Color
Get additional color on Graig Suvannavejh's coverage of popular stocks
2 years ago
IMCR
2 years ago
ITCI
2 years ago
IMCR
2 years ago
EYPT
2 years ago
AXSM
2 years ago
ADVM
3 years ago
BTAI
3 years ago
ITCI
3 years ago
AXSM
3 years ago
AXSM
3 years ago
HRMY
Graig Suvannavejh's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Palvella Therapeutics IncPVLA | 2 | Buy | $250.00 | +85.16% | Maintains | 5 days ago |
Insmed IncINSM | 10 | Buy | $204.00 | +36.61% | Maintains | 6 days ago |
Leonabio IncLONA | 4 | Buy | $10.00 | +77.62% | Upgrades | 11 days ago |
IMMIX Biopharma IncIMMX | 1 | Buy | $14.00 | +73.48% | Initiates Coverage On | 21 days ago |
Erasca IncERAS | 1 | Buy | $5.00 | -63.40% | Maintains | 3 months ago |
Terns Pharmaceuticals IncTERN | 9 | Buy | $54.00 | +28.21% | Maintains | 3 months ago |
Belite Bio IncBLTE | 2 | Buy | $194.00 | +1.94% | Upgrades | 3 months ago |
Harmony Biosciences Holdings IncHRMY | 21 | Buy | $46.00 | +61.18% | Maintains | 3 months ago |
Tarsus Pharmaceuticals IncTARS | 1 | Buy | $100.00 | +32.42% | Initiates Coverage On | 3 months ago |
Immatics NvIMTX | 4 | Buy | $23.00 | +122.44% | Maintains | 3 months ago |
Halozyme Therapeutics IncHALO | 5 | Hold | $56.00 | -19.46% | Maintains | 3 months ago |
Ideaya Biosciences IncIDYA | 3 | Buy | $46.00 | +42.86% | Maintains | 4 months ago |
Axsome Therapeutics IncAXSM | 22 | Buy | $202.00 | +23.25% | Maintains | 4 months ago |
Apellis Pharmaceuticals IncAPLS | 11 | Hold | $19.00 | -9.35% | Maintains | 4 months ago |
Bioxcel Therapeutics IncBTAI | 9 | Hold | $4.00 | +139.52% | Maintains | 6 months ago |
Kala Bio IncKALA | 1 | Buy | $30.00 | +7,794.74% | Initiates Coverage On | 6 months ago |
Alector IncALEC | 5 | Buy | $3.50 | +44.03% | Upgrades | 7 months ago |
Neumora Therapeutics IncNMRA | 2 | Buy | $5.00 | +43.27% | Maintains | 8 months ago |
Adverum Biotechnologies IncADVM | 5 | Buy | $12.00 | +175.23% | Maintains | 8 months ago |
Adaptimmune Therapeutics PLCADAPY | 3 | Hold | $0.50 | +825.93% | Downgrades | 8 months ago |
Immuneering CorpIMRX | 2 | Buy | $10.00 | +100.40% | Maintains | 8 months ago |
Corvus Pharmaceuticals IncCRVS | 3 | Buy | $11.00 | -39.76% | Maintains | 9 months ago |
Eyepoint IncEYPT | 5 | Buy | $26.00 | +48.06% | Maintains | 9 months ago |
Amylyx Pharmaceuticals IncAMLX | 7 | Buy | $8.00 | -47.26% | Maintains | 10 months ago |
Immunocore Holdings PLCIMCR | 8 | Hold | $33.00 | +2.17% | Maintains | a year ago |
Intra Cellular Therapies IncITCI | 11 | Hold | $132.00 | N/A | Downgrades | a year ago |
Autolus Therapeutics PLCAUTL | 1 | Strong Buy | $7.60 | N/A | Upgrades | a year ago |
Corbus Pharmaceuticals Holdings IncCRBP | 1 | Buy | $74.00 | N/A | Reiterates | a year ago |
Cerevel Therapeutics Holdings IncCERE | 9 | Hold | $45.00 | N/A | Maintains | 2 years ago |
Karuna Therapeutics IncKRTX | 3 | Strong Buy | $258.00 | N/A | Maintains | 3 years ago |
Rain Oncology IncRAIN2 | 5 | Hold | $1.00 | N/A | Downgrades | 3 years ago |
Vigil Neuroscience IncVIGL | 1 | Strong Buy | $15.00 | N/A | Initiates Coverage On | 3 years ago |
Rhythm Pharmaceuticals IncRYTM | 3 | Strong Buy | $35.00 | N/A | Maintains | 3 years ago |
Kodiak Sciences IncKOD | 4 | Hold | $8.00 | N/A | Maintains | 3 years ago |
Tg Therapeutics IncTGTX | 2 | Strong Sell | $26.00 | N/A | Downgrades | 4 years ago |
Disc Medicine IncIRON | 2 | Strong Buy | $18.00 | N/A | Maintains | 4 years ago |
Valneva SeVALN | 1 | Strong Buy | $34.00 | N/A | Initiates Coverage On | 5 years ago |
Design Therapeutics IncDSGN | 1 | Hold | $28.00 | N/A | Initiates Coverage On | 5 years ago |
Edgewise Therapeutics IncEWTX | 1 | Hold | $31.00 | N/A | Initiates Coverage On | 5 years ago |
Vor Biopharma IncVOR | 1 | Strong Sell | $380.00 | N/A | Initiates Coverage On | 5 years ago |
Innate Pharma SaIPHA | 1 | Hold | $4.75 | N/A | Initiates Coverage On | 5 years ago |
Arcutis Biotherapeutics IncARQT | 2 | Strong Buy | $36.00 | N/A | Upgrades | 5 years ago |
Cytokinetics IncCYTK | 1 | Hold | $16.00 | N/A | Initiates Coverage On | 5 years ago |
Galapagos NvGLPG | 1 | Strong Sell | N/A | N/A | Downgrades | 5 years ago |
Prelude Therapeutics IncPRLD | 1 | Hold | $37.00 | N/A | Initiates Coverage On | 5 years ago |
Jazz Pharmaceuticals PLCJAZZ | 1 | Strong Sell | $128.00 | N/A | Downgrades | 5 years ago |
Tricida IncTCDAQ | 1 | Hold | $10.00 | N/A | Downgrades | 6 years ago |
Flexion Therapeutics IncFLXN1 | 1 | Hold | $15.00 | N/A | Initiates Coverage On | 6 years ago |
Momenta Pharmaceuticals IncMNTA | 1 | Hold | $29.00 | N/A | Initiates Coverage On | 6 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 1 | Hold | $35.00 | N/A | Initiates Coverage On | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.